AAAAAA

   
Results: 1-8 |
Results: 8
Hypersensitivity reactions to carboplatin administration are common but not always severe: A 10-year experience
Authors: Polyzos, A Tsavaris, N Kosmas, C Arnaouti, T Kalahanis, N Tsigris, C Giannopoulos, A Karatzas, G Giannikos, L Sfikakis, PP
Citation: A. Polyzos et al., Hypersensitivity reactions to carboplatin administration are common but not always severe: A 10-year experience, ONCOL-BASEL, 61(2), 2001, pp. 129-133
Doxorubicin plus ifosfamide as salvage treatment for patients with advanced breast cancer refractory to epirubicin plus cyclophosphamide
Authors: Polyzos, A Kosmas, C Tsavaris, N Markopoulos, C Kalahanis, N Papadopoulos, O Arnaouti, T Sfikakis, PP
Citation: A. Polyzos et al., Doxorubicin plus ifosfamide as salvage treatment for patients with advanced breast cancer refractory to epirubicin plus cyclophosphamide, CLIN DRUG I, 19(5), 2000, pp. 349-355
Extravesical foreign body presenting as a bladder tumor
Authors: Kyriakou, G Kalahanis, N Kyroudi-Voulgari, A Zervas, A Mitropoulos, D
Citation: G. Kyriakou et al., Extravesical foreign body presenting as a bladder tumor, UROL INTERN, 65(4), 2000, pp. 224-225
Double biochemical modulation of 5-fluorouracil by methotrexate and folinic acid for the treatment of advanced colorectal cancer
Authors: Polyzos, A Tsavaris, N Kosmas, C Petrikos, G Stamatiadis, D Kalahanis, N Giannopoulos, A Karatzas, G Sfikakis, PP
Citation: A. Polyzos et al., Double biochemical modulation of 5-fluorouracil by methotrexate and folinic acid for the treatment of advanced colorectal cancer, CLIN DRUG I, 17(2), 1999, pp. 83-88
Second-line chemotherapy with cisplatin-ifosfamide in patients with ovarian cancer previously treated with carboplatin-cyclophosphamide
Authors: Polyzos, A Tsavaris, N Kosmas, C Petrikos, G Giannikos, L Kalahanis, N Papadopoulos, O Christodoulou, K Giannakopoulos, K Veslemes, M Katsilambros, N
Citation: A. Polyzos et al., Second-line chemotherapy with cisplatin-ifosfamide in patients with ovarian cancer previously treated with carboplatin-cyclophosphamide, J CHEMOTHER, 11(2), 1999, pp. 144-149
Expression patterns of the novel catenin p120cas in gastrointestinal cancers
Authors: Karayiannakis, AJ Syrigos, KN Alexiou, D Kalahanis, N Rosenberg, T Bastounis, E Pignatelli, M
Citation: Aj. Karayiannakis et al., Expression patterns of the novel catenin p120cas in gastrointestinal cancers, ANTICANC R, 19(5C), 1999, pp. 4401-4405
A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer
Authors: Polyzos, A Tsavaris, N Kosmas, C Giannikos, L Katsikas, M Kalahanis, N Karatzas, G Christodoulou, K Giannakopoulos, K Stamatiadis, D Katsilambros, N
Citation: A. Polyzos et al., A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer, ONCOL-BASEL, 56(4), 1999, pp. 291-296
Aberrant E-cadherin expression associated with loss of differentiation andadvanced stage in human pancreatic cancer
Authors: Karayiannakis, AJ Syrigos, KN Chatzigianni, E Papanikolaou, S Alexiou, D Kalahanis, N Rosenberg, T Bastounis, E
Citation: Aj. Karayiannakis et al., Aberrant E-cadherin expression associated with loss of differentiation andadvanced stage in human pancreatic cancer, ANTICANC R, 18(6A), 1998, pp. 4177-4180
Risultati: 1-8 |